A bottle of generic tablets produced by an Indian pharma firm. (Photographer: Dhiraj Singh/Bloomberg)

Natco Pharma’s Q2 Profit Meets Estimates

Natco Pharma Ltd.’s quarterly profit met estimates as its margins increased.

The drugmaker’s net profit rose 27.5 percent year-on-year to Rs 84.4 crore in the quarter ended September, according to its exchange filing. The consensus estimate of analysts tracked by Bloomberg stood at Rs 84.3 crore.

Revenue declined 7 percent to Rs 427 crore. That compares with the estimate of Rs 429 crore.

Natco’s earnings before interest, tax, depreciation and amortisation increased 16.3 percent to Rs 121.9 crore. EBITDA margin rose to 28.6 percent from 22.8 percent in the year-ago quarter.

Shares of the company rose as much as 4 percent to Rs 1,010 apiece today. That compares with a 2.92 percent rise in the Nifty Pharma Index.

BloombergQuint
Stay Updated With Stock Market News on BloombergQuint